Sodium channel (Dys)function and cardiac arrhythmias

Cardiovascular Therapeutics

Volumn 28, Issue 5, 2010, Pages 287-294

  Remme, Carol Ann ^a   Bezzina, Connie R ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Arrhythmias; Brugada syndrome; Long QT3; SCN5A; Sodium channels

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; MEXILETINE; QUINIDINE; RANOLAZINE; SODIUM CHANNEL; SODIUM CHANNEL BLOCKING AGENT; VOLTAGE GATED SODIUM CHANNEL;

GENE MUTATION; HEART ARRHYTHMIA; HEART FAILURE; HEART MUSCLE ISCHEMIA; HEART MUSCLE POTENTIAL; HEART VENTRICLE ARRHYTHMIA; HUMAN; LONG QT SYNDROME; PRIORITY JOURNAL; REVIEW; SODIUM CHANNELOPATHY; SODIUM CURRENT; SODIUM TRANSPORT;

ACTION POTENTIALS; ARRHYTHMIAS, CARDIAC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MUSCLE PROTEINS; MUTATION; MYOCYTES, CARDIAC; PROTEIN CONFORMATION; SODIUM CHANNELS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 77956413990     PISSN: 17555914     EISSN: 17555922     Source Type: Journal    
DOI: 10.1111/j.1755-5922.2010.00210.x     Document Type: Review

References (93)

1. Marban E, Yamagishi T, Tomaselli GF. Structure and function of voltage-gated sodium channels. J Physiol 1998 508 : 647 657.
2. Balser JR. The cardiac sodium channel: Gating function and molecular pharmacology. J Mol Cell Cardiol 2001 33 : 599 613.
3. Kass RS. Sodium channel inactivation in heart: A novel role of the carboxyterminal domain. J Cardiovasc Electrophysiol 2006 17 : S21 S25.
4. George AL, Jr. Inherited disorders of voltage-gated sodium channels. J Clin Invest 2005 115 : 1990 1999.
5. Dhar Malhotra J, Chen C, Rivolta I, et al. Characterization of sodium channel alpha and beta-subunits in rat and mouse cardiac myocytes. Circulation 2001 103 : 1303 1310.
6. Ko SH, Lenkowski PW, Lee HC, Mounsey JP, Patel MK. Modulation of Na(v)1.5 by beta1- and beta3-subunit co-expression in mammalian cells. Pflugers Arch 2005 449 : 403 412.
7. Medeiros-Domingo A, Kaku T, Tester DJ, et al. SCN4B-encoded sodium channel beta4 subunit in congenital long-QT syndrome. Circulation 2007 116 : 134 142.
8. Abriel H, Kass RS. Regulation of the voltage-gated cardiac sodium channel Nav1.5 by interacting proteins. Trends Cardiovasc Med 2005 15 : 35 40. (Pubitemid 40417543)
9. London B, Michalec M, Mehdi H, et al. Mutation in glycerol-3-phosphate dehydrogenase 1 like gene (GPD1-L) decreases cardiac Na+ current and causes inherited arrhythmias. Circulation 2007 116 : 2260 2268.
10. Wu L, Yong SL, Fan C, et al. Identification of a new co-factor, MOG1, required for the full function of cardiac sodium channel Nav 1.5. J Biol Chem 2008 283 : 6968 6978.
11. Ruan Y, Liu N, Napolitano C, Priori SG. Therapeutic strategies for long-QT syndrome: Does the molecular substrate matter? Circ Arrhythm Electrophysiol 2008 1 : 290 297.
12. Rowinsky EK, McGuire WP, Guarnieri T, Fisherman JS, Christian MC, Donehower RC. Cardiac disturbances during the administration of taxol. J Clin Oncol 1991 9 : 1704 1712.
13. Casini S, Tan HL, Demirayak I, et al. Tubulin polymerization modifies cardiac sodium channel expression and gating. Cardiovasc Res 2010 85 : 691 700.
14. Amin AS, Verkerk AO, Bhuiyan ZA, Wilde AA, Tan HL. Novel Brugada syndrome-causing mutation in ion-conducting pore of cardiac Na+ channel does not affect ion selectivity properties. Acta Physiol Scand 2005 185 : 291 301.
15. Yoo S, Dobrzynski H, Fedorov VV, et al. Localization of Na+ channel isoforms at the atrioventricular junction and atrioventricular node in the rat. Circulation 2006 114 : 1360 1371.
16. Remme CA, Verkerk AO, Hoogaars WM, et al. The cardiac sodium channel displays differential distribution in the conduction system and transmural heterogeneity in the murine ventricular myocardium. Basic Res Cardiol 2009 104 : 511 522.
17. Ashamalla SM, Navarro D, Ward CA. Gradient of sodium current across the left ventricular wall of adult rat hearts. J Physiol 2001 536 : 439 443.
18. Wiegerinck RF, van Veen TAB, Belterman CN, Schumacher CA, Noorman M, de Bakker JMT, Coronel R. Transmural dispersion of refractoriness and conduction velocity is associated with heterogeneously reduced connexin43 in a rabbit model of heart failure. Heart Rhythm 2008 5 : 1178 1185.
19. Burashnikov A, Di Diego JM, Zygmunt AC, Belardinelli L, Antzelevitch C. Atrium-selective sodium channel block as a strategy for suppression of atrial fibrillation: Differences in sodium channel inactivation between atria and ventricles and the role of ranolazine. Circulation 2007 116 : 1449 1457.
20. Li GR, Lau CP, Shrier A. Heterogeneity of sodium current in atrial vs epicardial ventricular myocytes of adult guinea pig hearts. J Mol Cell Cardiol 2002 34 : 1185 1194.
21. Wang Q, Shen J, Splawski I, et al. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell 1995 80 : 805 811.
22. Chen Q, Kirsch GE, Zhang D, et al. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature 1998 392 : 293 296.
23. Schott JJ, Alshinawi C, Kyndt F, et al. Cardiac conduction defects associate with mutations in SCN5A. Nat Genet 1999 23 : 20 21.
24. Tan HL, Bink-Boelkens MT, Bezzina CR, et al. A sodium-channel mutation causes isolated cardiac conduction disease. Nature 2001 409 : 1043 1047.
25. Benson DW, Wang DW, Dyment M, et al. Congenital sick sinus syndrome caused by recessive mutations in the cardiac sodium channel gene (SCN5A). J Clin Invest 2003 112 : 1019 1028.
26. Groenewegen WA, Firouzi M, Bezzina CR, et al. A cardiac sodium channel mutation cosegregates with a rare connexin40 genotype in familial atrial standstill. Circ Res 2003 92 : 14 22.
27. McNair WP, Ku L, Taylor MR, Fain PR, Dao D, Wolfel E, Mestroni L. SCN5A mutation associated withdilated cardiomyopathy, conduction disorder, and arrhythmia. Circulation 2004 110 : 2163 2167.
28. Olson TM, Michels VV, Ballew JD, et al. Sodium channel mutations and susceptibility to heart failure and atrial fibrillation. JAMA 2005 293 : 447 454.
29. Ellinor PT, Nam EG, Shea MA, Milan DJ, Ruskin JN, MacRae CA. Cardiac sodium channel mutation in atrial fibrillation. Heart Rhythm 2008 5 : 99 105.
30. Schwartz PJ, Priori SG, Spazzolini C, et al. Genotype-phenotype correlation in the long-QT syndrome: Gene-specific triggers for life-threatening arrhythmias. Circulation 2001 103 : 89 95.
31. Zareba W, Sattari MN, Rosero S, Couderc JP, Moss AJ. Altered atrial, atrioventricular, and ventricular conduction in patients with the long QT syndrome caused by the DeltaKPQ SCN5A sodium channel gene mutation. Am J Cardiol 2001 88 : 1311 1314.
32. Bennett PB, Yazawa K, Makita N, George AL. Molecular mechanism for an inherited cardiac arrhythmia. Nature 1995 376 : 683 685.
33. Wedekind H, Smits JP, Schulze-Bahr E, et al. De novo mutation in the SCN5A gene associated with early onset of sudden infant death. Circulation 2001 104 : 1158 1164.
34. Rivolta I, Abriel H, Tateyama M, et al. Inherited Brugada and long QT-3 syndrome mutations of a single residue of the cardiac sodium channel confer distinct channel and clinical phenotypes. J Biol Chem 2001 276 : 30623 30630.
35. Clancy CE, Tateyama M, Liu H, Wehrens XH, Kass RS. Nonequilibrium gating in cardiac Na+ channels: An original mechanism of arrhythmia. Circulation 2003 107 : 2233 2237.
36. Groenewegen WA, Bezzina CR, van Tintelen JP, et al. A novel LQT3 mutation implicates the human cardiac sodium channel domain IVS6 in inactivation kinetics. Cardiovasc Res 2003 57 : 1072 1078.
37. Meregalli PG, Wilde AA, Tan HL. Pathophysiological mechanisms of Brugada syndrome: Depolarization disorder, repolarization disorder, or more? Cardiovasc Res 2005 67 : 367 378.
38. Antzelevitch C. Brugada syndrome. Pacing Clin Electrophysiol 2006 29 : 1130 1159.
39. Dumaine R, Towbin JA, Brugada P, et al. Ionic mechanisms responsible for the electrocardiographic phenotype of the Brugada syndrome are temperature dependent. Circ Res 1999 85 : 803 809.
40. Amin AS, Meregalli PG, Bardai A, Wilde AA, Tan HL. Fever increases the risk for cardiac arrest in the Brugada syndrome. Ann Intern Med 2008 149 : 216 218.
41. Antzelevitch C, Fish JM. Therapy for the Brugada syndrome. Handb Exp Pharmacol 2006 171 : 305 330.
42. Tan HL, Bezzina CR, Smits JP, Verkerk AO, Wilde AA. Genetic control of sodium channel function. Cardiovasc Res 2003 57 : 961 973.
43. Viswanathan PC, Balser JR. Inherited sodium channelopathies: A continuum of channel dysfunction. Trends Cardiovasc Med 2004 14 : 28 35.
44. Postema PG, van Dessel PF, de Bakker JM, et al. Slow and discontinuous conduction conspire in Brugada syndrome: A right ventricular mapping and stimulation study. Circ Arrhythm Electrophysiol 2008 1 : 379 386.
45. Coronel R, Casini S, Koopmann TT, et al. Right ventricular fibrosis and conduction delay in a patient with clinical signs of Brugada syndrome: A combined electrophysiological, genetic, histopathologic, and computational study. Circulation 2005 112 : 2769 2777.
46. Tukkie R, Sogaard P, Vleugels J, de Groot I, Wilde AA, Tan HL. Delay in right ventricular activation contributes to Brugada syndrome. Circulation 2004 109 : 1272 1277.
47. Antzelevitch C, Brugada P, Borggrefe M, et al. Brugada syndrome: Report of the second consensus conference. Heart Rhythm 2005 2 : 429 440. (Pubitemid 40439292)
48. Wolf CM, Berul CI. Inherited conduction system abnormalities-one group of diseases, many genes. J Cardiovasc Electrophysiol 2006 17 : 446 455.
49. Kyndt F, Probst V, Potet F, et al. Novel SCN5A mutation leading either to isolated cardiac conduction defect or Brugada syndrome in a large French family. Circulation 2001 104 : 3081 3086.
50. Smits JP, Koopmann TT, Wilders R, et al. A mutation in the human cardiac sodium channel (E161K) contributes to sick sinus syndrome, conduction disease and Brugada syndrome in two families. J Mol Cell Cardiol 2005 38 : 969 981.
51. Lei M, Huang CL, Zhang Y. Genetic Na+ channelopathies and sinus node dysfunction. Prog Biophys Mol Biol 2008 98 : 171 118.
52. Veldkamp MW, Wilders R, Baartscheer A, Zegers JG, Bezzina CR, Wilde AA. Contribution of sodium channel mutations to bradycardia and sinus node dysfunction in LQT3 families. Circ Res 2003 92 : 976 983.
53. Bezzina CR, Rook MB, Groenewegen WA, et al. Compound heterozygosity for mutations (W156X and R225W) in SCN5A associated with severe cardiac conduction disturbances and degenerative changes in the conduction system. Circ Res 2003 92 : 159 168.
54. Bezzina CR, Remme CA. Dilated cardiomyopathy due to sodium channel dysfunction: What is the connection? Circ Arrhythm Electrophysiol 2008 1 : 80 82.
55. Nguyen TP, Wang DW, Rhodes TH, George AL Jr. Divergent biophysical defects caused by mutant sodium channels in dilated cardiomyopathy with arrhythmia. Circ Res 2008 102 : 364 371.
56. Remme CA, Wilde AA, Bezzina CR. Cardiac sodium channel overlap syndromes: Different faces of SCN5A mutations. Trends Cardiovasc Med 2008 18 : 78 87.
57. Bezzina C, Veldkamp MW, Van Den Berg MP, et al. A single Na+ channel mutation causing both long-QT and Brugada syndromes. Circ Res 1999 85 : 1206 1213.
58. Van Den Berg MP, Wilde AA, Viersma TJW, et al. Possible bradycardic mode of death and successful pacemaker treatment in a large family with features of long QT syndrome type 3 and Brugada syndrome. J Cardiovasc Electrophysiol 2001 12 : 630 636.
59. Veldkamp MW, Viswanathan PC, Bezzina C, Baartscheer A, Wilde AA, Balser JR. Two distinct congenital arrhythmias evoked by a multidysfunctional Na+ channel. Circ Res 2000 86 : e91 e97.
60. Remme CA, Verkerk AO, Nuyens D, et al. Overlap syndrome of cardiac sodium channel disease in mice carrying the equivalent mutation of human SCN5A-1795insD. Circulation 2006 114 : 2584 2594.
61. Probst V, Kyndt F, Potet F, et al. Haploinsufficiency in combination with aging causes SCN5A-linked hereditary Lenegre disease. J Am Coll Cardiol 2003 41 : 643 652.
62. Remme CA, Wilde AA. SCN5A overlap syndromes: No end to disease complexity? Europace 2008 10 : 1253 1255.
63. Remme CA, Scicluna BP, Verkerk AO, et al. Genetically determined differences in sodium current characteristics modulate conduction disease severity in mice with cardiac sodium channelopathy. Circ Res 2009 104 : 1283 1292.
64. Zipes DP, Wellens HJJ. Sudden cardiac death. Circulation 1998 98 : 2334 2351.
65. Perron AD, Sweeney T. Arrhythmic complications of acute coronary syndromes. Emerg Med Clin North Am 2005 23 : 1065 1082.
66. Janse MJ, Wit AL. Electrophysiological mechanisms of ventricular arrhythmias resulting from myocardial ischemia and infarction. Physiol Rev 1989 69 : 1049 1169.
67. Cascio WE. Myocardial ischemia: What factors determine arrhythmogenesis? J Cardiovasc Electrophysiol 2001 12 : 726 729.
68. Fozzard HA, Makielski JC. The electrophysiology of acute myocardial ischemia. Ann Rev Med 1985 36 : 275 284.
69. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary report: Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989 321 : 406 412.
70. Janse MJ, Opthof T, Kléber AG. Animal models of cardiac arrhythmias. Cardiovasc Res 1998 39 : 165 177.
71. Clements-Jewery H, Hearse DJ, Curtis MJ. Phase 2 ventricular arrhythmias in acute myocardial infarction. Br J Pharmacol 2005 145 : 551 564.
72. Dekker LR, Bezzina CR, Henriques JP, et al. Familial sudden death is an important risk factor for primary ventricular fibrillation: A case-control study in acute myocardial infarction patients. Circulation 2006 114 : 1140 1145.
73. Oliva A, Hu D, Viskin S, et al. SCN5A mutation associated with acute myocardial infarction. Leg Med (Tokyo) 2009 11 : S206 S209.
74. Goldman S, Johnson G, Cohn JN, Cintron G, Smith R, Francis G. Mechanism of death in heart failure. The Vasodilator-Heart Failure Trials. The V-HeFT VA Cooperative Studies Group. Circulation 1993 87 : VI24 VI31.
75. Narang R, Cleland JG, Erhardt L, et al. Mode of death in chronic heart failure. A request and proposition for more accurate classification. Eur Heart J 1996 17 : 1390 1403.
76. Nattel S, Maguy A, Le Bouter S, Yeh YH. Arrhythmogenic ion-channel remodeling in the heart: Heart failure, myocardial infarction, and atrial fibrillation. Physiol Rev 2007 87 : 425 456. (Pubitemid 47084677)
77. Janse MJ. Electrophysiological changes in heart failure and their relationship to arrhythmogenesis. Cardiovasc Res 2004 61 : 208 217.
78. Valdivia CR, Chu WW, Pu J, et al. Increased late sodium current in myocytes from a canine heart failure model and from failing human heart. J Mol Cell Cardiol 2005 38 : 475 483.
79. Wagner S, Dybkova N, Rasenack EC, et al. Ca2+/calmodulindependent protein kinase II regulates cardiac Na+ channels. J Clin Invest 2006 116 : 3127 3138.
80. Ufret-Vincenty CA, Baro DJ, Lederer WJ, Rockman HA, Quinones LE, Santana LF. Role of sodium channel deglycosylation in the genesis of cardiac arrhythmias in heart failure. J Biol Chem 2001 276 : 28197 28203.
81. Shang LL, Pfahnl AE, Sanyal S, et al. Human heart failure is associated with abnormal C-terminal splicing variants in the cardiac sodium channel. Circ Res 2007 101 : 1146 1154.
82. Casini S, Verkerk AO, van Borren MM, van Ginneken AC, Veldkamp MW, de Bakker JM, Tan HL. Intracellular calcium modulation of voltage-gated sodium channels in ventricular myocytes. Cardiovasc Res 2009 81 : 72 81.
83. Priori SG, Napolitano C, Schwartz PJ, et al. Association of long QT syndrome loci and cardiac events among patients treated with ß-blockers. JAMA 2004 292 : 1341 1344.
84. Schwartz PJ, Spazzolini C, Crotti L. All LQT3 patients need an ICD: True or false? Heart Rhythm 2009 6 : 113 120.
85. Eckardt L. LQT3: Who is at risk for sudden cardiac death? Heart Rhythm 2009 6 : 121 122.
86. Shimizu W, Aiba T, Antzelevitch C. Specific therapy based on the genotype and cellular mechanism in inherited cardiac arrhythmias. Long QT syndrome and Brugada syndrome. Curr Pharmaceut Design 2005 11 : 1561 1572.
87. Mönnig G, Köbe J, Löher A, et al. Implantable cardioverterdefibrillator therapy in patients with congenital long-QT syndrome: A long-term follow-up. Heart Rhythm 2005 2 : 497 504.
88. Belhassen B, Viskin S. Pharmacologic approach to therapy of Brugada syndrome: Quinidine as an alternative to ICD therapy. In : Antzelevitch C, Brugada P, Brugada J, Brugada R, editors. The Brugada syndrome: From bench to bedside. Oxford : Blackwell Futura, 2004 202 211.
89. Alings M, Dekker L, Sadee A, Wilde A. Quinidine induced electrocardiographic normalization in two patients with Brugada syndrome. Pacing Clin Electrophysiol 2001 24 : 1420 1422.
90. Antzelevitch C, Belardinelli L, Zygmunt AC, et al. Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties. Circulation 2004 110 : 904 910. (Pubitemid 39136212)
91. Moss AJ, Zareba W, Schwarz KQ, Rosero S, McNitt S, Robinson JL. Ranolazine shortens repolarization in patients with sustained inward sodium current due to type-3 long-QT syndrome. J Cardiovasc Electrophysiol 2008 19 : 1289 1293.
92. Hale SL, Shryock JC, Belardinelli L, Sweeney M, Kloner RA. Late sodium current inhibition as a new cardioprotective approach. J Mol Cell Cardiol 2008 44 : 954 967.
93. Antzelevitch C, Burashnikov A. Atrial-selective sodium channel block as a novel strategy for the management of atrial fibrillation. J Electrocardiol 2009 42 : 543 548.